HempMeds® Mexico, a subsidiary of Medical Marijuana, Inc., has announced a new permit granted by the Mexican federal government to import its CBD derivatives. The importation permit gives HempMeds Mexico permission to import their flagship product, Real Scientific Hemp Oil-XTM (RSHO-XTM) to help a patient manage the symptoms associated with cancer treatments.
The patient granted import permission from the Mexican Health Authority is a 44-year-old woman diagnosed with Stage 5 breast cancer. She’s received approval to use the RSHO-XTM in the treatment of neuropathic pain related to chemotherapy.
“This is a great opportunity to show the benefits that cannabinoids have as a solution to health conditions that haven’t met any result by traditional medical procedures,” said Carlos Gonzalez, Chief Operating Officer of HempMeds Mexico, in a statement. “We hope that by using RSHO-X, this patient will carry a better quality of life after each chemotherapy treatment.”
Neuropathic pain is a common, but extremely unpleasant side effect of chemotherapy treatments. Studies have shown that cannabinoids like CBD are effective for managing several types of pain, including pain related to chemotherapy that has otherwise proven refractory to other traditional treatments.
HempMeds® Mexico is the first company to have a medical cannabis product approved for import into Mexico. Patients can legally import the CBD hemp oil by obtaining a doctor’s prescription and import certificate from the Federal Commission for the Protection Against Sanitary Risk (COFEPRIS). Doctors can prescribe RSHO-XTM for any condition, disease, or disorder, and more than 150 permits have been granted for conditions like epilepsy and diabetic neuropathy.
“We applaud and wholeheartedly stand by the decision made by COFEPRIS,” said Dr. Stuart Titus, Chief Executive Officer of Medical Marijuana, Inc., in a statement. “Our company continues to do everything in our power to lessen the suffering and enhance the comfort of anyone forced to live through pain. The decision made by Mexico to allow our subsidiary’s product to assist in the general well being of this female patient sets the stage for a truly remarkable precedent. We encourage all others to follow the lead set out by COFEPRIS in utilizing our CBD Hemp Oil products as a step forward on the path towards alleviating pain.”
To follow the legal demands of COFEPRIS, HempMeds® Mexico developed RSHO-XTM, a first-of-its kind cannabidiol (CBD) hemp oil that is completely free of tetrahydrocannabinol (THC), the psychoactive chemical compound that causes a high.
The announcement by HempMeds® Mexico is just the latest in a string of recent exciting developments for the company. Celebrating its one-year anniversary this month, HempMeds® Mexico has worked to open several new Latin American markets over the past 12 months, expanding efforts into Argentina, Chile, Colombia, and Paraguay.
RSHO-XTM THC-free CBD oil was at the center of one recent study that examined the effects of CBD and epilepsy. The survey, conducted by renowned Mexican physician Dr. Carlos G. Aguirre Velazquez, found that 60% of the 53 cases of epileptic children treated with CBD hemp oil saw a reduction in seizures.
In what appears to be an opportunity for greater expansion, last month lawmakers in Mexico passed significant medical marijuana reform. The new law could open access to multiple types of cannabis products, including those containing THC for the first time. The reform initiative passed the Senate of the Republic and is awaiting consideration by the Chamber of Deputies. If it passes there, it will become law, giving HempMeds® Mexico the unique opportunity to begin exporting its entire line of CBD hemp oil products to Mexico.